Evommune is a clinical-stage biotech developing therapies for chronic inflammatory and immune-mediated diseases using a human tissue-based discovery approach. It aims to treat patients with conditions like chronic urticaria and other inflammatory skin and immune disorders. Its tissue-based platform is designed to find drugs that both relieve symptoms and halt disease progression.
acquisitions n=0
No cited completed company acquisition recorded.
traction n=0
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
valuations n=0
No cited valuation with an explicit basis is recorded.
revenue multiples n=0
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
Cloudflare, WordPress, Magnific Popup, Yoast SEO 27.4, Google Tag Manager, FitVids.JS, Font Awesome, jQuery Migrate, jQuery Mobile, Easy Pie Chart, Cloudflare Bot Management, Zepto